Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock One fast-growing digital health stock just secured a notable new backer—right as its financial momentum hits a fresh gear.
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? One fund is quietly buying into ACADIA — just as the company posts one of its strongest quarters in years.
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of commercialization.
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying A science-first biotech fund is leaning deeper into one company just as its lead program delivers some compelling early neuro data.
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover One biotech-focused investment firm cashed out of its stake in this drug developer as the stock soared—but seemingly missed out on a massive premium by mere weeks.
Why Cg Oncology Stock Rocketed 7% Higher Today One pundit believes this is a clinical-stage company well worth watching.
CG Oncology Stock Signals Bullish Momentum Ahead CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here's what to track...
Which stocks are moving before the opening bell on Tuesday? The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them?
These stocks are moving in today's session Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Which stocks are gapping on Monday? Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why CG Oncology shared new Phase 3 trial results showing durable responses and strong patient compliance in high-risk bladder cancer treatment at AUA 2025.
These stocks are moving in today's pre-market session Wondering what's happening in Monday's pre-market session? Find an overview in this article.
